Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Exp Cell Res. 2010 Jul 13;316(16):2644–2653. doi: 10.1016/j.yexcr.2010.06.028

Figure 8. Schematic of the PTEN/PI3K/Akt/mTOR axis in fibroblasts proposed in this manuscript.

Figure 8

mTOR, in complex with rictor and gβL, phosphorylates Akt on S473. Akt is subsequently phosphorylated on T308 by the actions of PDK1 downstream of PI3K. PTEN negatively regulates this activity. Akt directly phosphorylates and activates SF2/ASF to enhance EDA splicing and, through a series of steps involving the tuberous sclerosis complex and Rheb (depicted as the broken arrow), promotes mTOR/raptor/gβL activity. mTOR/raptor/gβL activates p70S6K, which promotes FN protein translation as well as inhibiting insulin receptor substrate-1 (IRS-1) thereby inhibiting PI3K activity. In the absence of PTEN, high basal Akt activity results in augmented EDA splicing and p70S6K-mediated FN expression. The FN expression is blocked by rapamycin. In cells with normal PTEN expression, PI3K activity is more sensitive to IRS-1 regulation and rapamycin in this case augments PI3K/Akt activity.